Biopharmaceuticals
Issues related to corporate and international tax reform including issues related to IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 174, and 965.
TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE WASHINGTON TAX & PUBLIC POLICY GROUP
505 9th Street NW, Suite 830, Washington, DC, 20004, US
GREGORY NICKERSON (Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee) JAN FOWLER (Leg. Asst, Sen. Voinovich; Leg. Asst, Leg. Correspondent, Staff Asst., Intern for Rep. McCrery) BRIAN DIFFELL (Policy Advisor, Senate Rep. Conference; Leg. Director, Sen. Blunt; Leg. Director, Rep. Blunt; Sr. Policy Advisor, House Rep. Whip; Sr. Policy Advisor, House Maj. Whi; Research Analyst, House Maj. Whip; Special to Asst. Chief Deputy Whip)
Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee Leg. Asst, Sen. Voinovich; Leg. Asst, Leg. Correspondent, Staff Asst., Intern for Rep. McCrery Policy Advisor, Senate Rep. Conference; Leg. Director, Sen. Blunt; Leg. Director, Rep. Blunt; Sr. Policy Advisor, House Rep. Whip; Sr. Policy Advisor, House Maj. Whi; Research Analyst, House Maj. Whip; Special to Asst. Chief Deputy Whip